One of his Dr. Richard Neubig's goals when he came to MSU in 2013 was to create and build a Drug Discovery program, a relatively new direction in the world of drug research. Mission accomplished.
She was going to stay only two years at MSU. That was nearly 50 years ago and now Dr. Susan Barman can't imagine having taken her skills as a scientist and researcher anywhere else. "I really liked what I was doing here," she said.
Her study of the cardiovascular system looks at how certain drugs impact the prolongation of the heart’s QT interval, which is a risk factor for the development of ventricular arrhythmia.
Drs. Nathan Tykocki, Kin Sing Lee, and Adam Lauver will have new titles added to their names after the Michigan State University Board of Trustees on June 28 approved their promotions to Associate Professor.